Status:
ENROLLING_BY_INVITATION
Omega Tots Long Term Follow-up
Lead Sponsor:
Sarah Keim
Collaborating Sponsors:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions:
Preterm Birth
Child Development
Eligibility:
All Genders
8-10 years
Phase:
NA
Brief Summary
This is a continuation study to the Omega Tots trial (NCT01576783). The purpose of this study is to follow-up with participants of the original study to determine the long-term effect a daily fatty ac...
Detailed Description
The overall objective with the present study is to determine the long-term effects of docosahexaenoic acid (DHA) plus arachidonic acid (AA) supplementation on general cognitive ability, language, and ...
Eligibility Criteria
Inclusion
- Previous participation in Omega Tots (NCT01576783).
- Current age of 8 years, 180 days to 10 years, 180 days.
Exclusion
- Child in custody of children's services for their window of eligibility
Key Trial Info
Start Date :
December 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
377 Patients enrolled
Trial Details
Trial ID
NCT05191823
Start Date
December 1 2021
End Date
June 30 2026
Last Update
May 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nationwide Children's Hospital
Columbus, Ohio, United States, 43205